Tag Archives: europe

Measles surge in Britain years after vaccine/autism scare

More than a decade ago, British parents refused to give measles shots to at least a million children because of a vaccine scare that raised the specter of autism. Now, health officials are scrambling to catch up and stop a growing epidemic of the contagious disease. This year, the U.K. has had more than 1,200 cases of measles, after a record number of nearly 2,000 cases last year. The country once recorded only several dozen cases every year. It now ranks second in Europe, behind only Romania. Last month, emergency vaccination clinics were held every weekend in Wales, the epicenter of the outbreak. Immunization drives have also started elsewhere in the country, with officials aiming to reach 1 million children aged 10 to 16. “This is the legacy of the Wakefield scare,” said Dr. David Elliman, spokesman for the Royal College of Paediatrics and Child Health, referring to a paper published in 1998 by Andrew Wakefield and colleagues. That work suggested a link between autism and the combined childhood vaccine for measles, mumps and rubella, called the MMR. Several large scientific studies failed to find any connection, the theory was rejected by at least a dozen major U.K. medical groups and the paper was eventually retracted by the journal that published it. Still, MMR immunization rates plummeted across the U.K. as fearful parents abandoned the vaccine - from rates over 90 percent to 54 percent. Nearly 15 years later, the rumors about MMR are still having an impact. Now there's “this group of older children who have never been immunized who are a large pool of infections,” Elliman said. The majority of those getting sick in the U.K. - including a significant number of older children and teens - had never been vaccinated. Almost 20 of the more than 100 seriously ill children have been hospitalized and 15 have suffered complications including pneumonia and meningitis. One adult with measles has died, though it's unclear if it was the disease that killed him. The first measles vaccines were introduced in the 1960s, which dramatically cut cases of the rash-causing illness. Since 2001, measles deaths have dropped by about 70 percent worldwide; Cambodia recently marked more than a year without a single case. Globally, though, measles is still one of the leading causes of death in children under 5 and kills more than 150,000 people every year, mostly in developing countries. Measles is highly contagious and is spread by coughing, sneezing and close personal contact with infected people; symptoms include a fever, cough, and a rash on the face. Across the U.K., about 90 percent of children under 5 are vaccinated against measles and have received the necessary two doses of the vaccine. But among children now aged 10 to 16, the vaccination rate is slightly below 50 percent in some regions. To stop measles outbreaks, more than 95 percent of children need to be fully immunized. In some parts of the U.K., the rate is still below 80 percent. Unlike in the United States, where most states require children to be vaccinated against measles before starting school, no such regulations exist in Britain. Parents are advised to have their children immunized, but Britain's Department of Health said it had no plans to consider introducing mandatory vaccination. Last year, there were 55 reported cases of measles in the United States, where the measles vaccination rate is above 90 percent. So far this year, there have been 22 cases, including three that were traced to Britain. In previous years, the U.K. has sometimes exported more cases of measles to the U.S. than some countries in Africa. Portia Ncube, a health worker at an East London clinic, said the struggle to convince parents to get the MMR shot is being helped by the measles epidemic in Wales. “They see what's happening in Wales, so some of them are now sensible enough to come in and get their children vaccinated,” she said. Clinic patient Ellen Christensen, mother of an infant son, acknowledged she had previously had some “irrational qualms” about the MMR vaccine. “But after reading more about it, I know now that immunization is not only good for your own child, it's good for everyone,” she said.source : http://www.foxnews.com/health/2013/05/20/measles-surge-in-britain-years-after-vaccineautism-scare/

WHO: Saudi Arabia has another case of new coronavirus

Saudi Arabia has reported another case of infection in a concentrated outbreak of a new strain of a virus that emerged in the Middle East last year and spread into Europe, the World Health Organization (WHO) said on Saturday. In a disease outbreak update issued from its Geneva headquarters, the WHO said the latest patient is an 81-year-old woman with multiple medical conditions. She became ill on April 28 and is in a critical but stable condition. Worldwide, there have now been 41 laboratory-confirmed infections, including 20 deaths, since the new coronavirus was identified by scientists in September 2012. The novel coronavirus, which had been known as by the acronym nCoV but which some scientific journals now refer to as Middle East Respiratory Syndrome coronavirus, or MERS, belongs to the same family as viruses that cause common colds and the one that caused a deadly outbreak of Severe Acute Respiratory Syndrome (SARS) in 2003. MERS cases have so far been reported in Saudi Arabia, Jordan, Qatar, Britain, Germany and France, but Saudi Arabia has had the vast majority of cases. The WHO said that latest patient was in the same clinic in eastern Saudi Arabia that has seen 22 cases, nine of them fatal, since April 8. WHO experts visiting Saudi Arabia to consult with the authorities on the outbreak have said it seemed likely the new virus could be passed between humans, but only after prolonged, close contact.source : http://www.foxnews.com/health/2013/05/20/who-saudi-arabia-has-another-case-new-coronavirus/

FDA approves new drug to fight prostate cancer

German drugmaker Bayer and its development partner Algeta won approval from U.S. regulators for a prostate cancer drug that could eventually generate more than 1 billion euros ($1.31 billion) in annual sales. The Food and Drug Administration, which has reviewed Xofigo under its priority program, said on Wednesday the injection is cleared for treatment of bone metastases in men whose cancer has spread after receiving medical or surgical therapy to lower testosterone. Bayer licensed Xofigo, also called radium-223 dichloride, from Norway's Algeta in 2009 and the two companies will co-promote the injection in the U.S. Bayer has also requested approval for the drug in Europe, where it would market the drug alone. The drug, which according to Bayer could become a “blockbuster” product with annual sales of least 1 billion euros, has some properties of calcium. That makes it cling to cancerous bone cells and then destroy them via alpha rays, which is more targeted than the shotgun approach of conventional radiotherapy.source : http://www.foxnews.com/health/2013/05/15/bayer-algeta-win-fda-approval-for-prostate-cancer-drug/

New SARS? Deadly virus can likely pass person-to-person, WHO says

World Health Organization (WHO) officials said on Sunday it seemed likely a new coronavirus that has killed at least 18 people in the Middle East and Europe could be passed between humans, but only after prolonged contact. A virus from the same family triggered the outbreak of Severe Acute Respiratory Syndrome (SARS) that swept the world after emerging in Asia and killed 775 people in 2003. On Sunday French authorities announced that a second man had been diagnosed with the disease after sharing a hospital room with France's only other sufferer. WHO Assistant Director-General Keiji Fukuda told reporters in Saudi Arabia, the site of the largest cluster of infections, there was no evidence so far the virus was able to sustain “generalized transmission in communities” - a scenario that would raise the specter of a pandemic. But he added: “Of most concern ... is the fact that the different clusters seen in multiple countries ... increasingly support the hypothesis that when there is close contact, this novel coronavirus can transmit from person to person. “There is a need for countries to ... increase levels of awareness,” he said. A public health expert who declined to be identified, said “close contact” meant being in the same small, enclosed space with an infected person for a prolonged period. The virus first emerged in the Gulf last year, but cases have also been recorded in Britain and France among people who had recently been in the Middle East. A total of 34 cases worldwide have been confirmed by blood tests so far. NEW DEATHS Saudi Deputy Health Minister for Public Health Ziad Memish told reporters that, of 15 confirmed cases in the most recent outbreak, in al-Ahsa district of Eastern Province, nine had died, two more than previously reported. Saudi Arabia's Health Ministry said in a statement the country had had 24 confirmed cases since last summer, of whom 15 had died. Fukuda said he was not sure if the two newly reported Saudi deaths were included in the numbers confirmed by the WHO. Memish added that three suspected cases in Saudi Arabia were still under investigation, including previous negative results that were being re-examined. The first French patient was confirmed as suffering from the disease on Wednesday after travelling in the Gulf. The second patient was transferred to intensive care on Sunday after the two men shared a room in a hospital in Lille. Professor Benoit Guery, head of the Lille hospital's infectious diseases unit, said the first patient had not been immediately isolated because he presented “quite atypical” symptoms. He added in comments broadcast by BFMTV channel the case suggested that airborne transmission of the virus was possible, though still unusual, and that the public “should not be concerned” as there had been only 34 cases globally in a year. Fukuda, part of a WHO team visiting Saudi Arabia to investigate the spread of the disease, said although no specific vaccine or medication was yet available for novel coronavirus, patients were responding to treatment. “The care that is taken in the hospitals, in terms of using respirators well, in terms of treating pneumonia, in terms of treating complications, in terms of providing support, these steps can get patients through this very severe illness,” he said. Fukuda said that as far as he knew all cases in the latest outbreak in al-Ahsa district were directly or indirectly linked to one hospital. He added that Saudi Arabian authorities had taken novel coronavirus very seriously and had initiated necessary health measures such as increased surveillance systems.source : http://www.foxnews.com/health/2013/05/13/new-sars-like-virus-can-probably-pass-person-to-person-who-says/